GENERATE BIOMEDICINES INC (GENB): Institutional Ownership
Hedge funds and institutional managers reporting a position in GENB. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$2.3M
Across holders
Last Price
$16.47
2026-06-26
Sector
GICS
Holder activity5 new0 added0 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 79K | $994K | 43.5% | 0.0% | New | — | Q1 2026 |
| Qube Research & Technologies Ltd CIK 0001729829 | Hedge Fund | 50K | $628K | 27.5% | 0.0% | New | — | Q1 2026 |
| TUDOR INVESTMENT CORP ET AL CIK 0000923093 | Hedge Fund | 24K | $298K | 13.0% | 0.0% | New | — | Q1 2026 |
| Hudson Bay Capital Management LP CIK 0001393825 | Hedge Fund | 17K | $208K | 9.1% | 0.0% | New | — | Q1 2026 |
| Brevan Howard Capital Management LP CIK 0001512857 | Hedge Fund | 13K | $157K | 6.9% | 0.0% | New | — | Q1 2026 |
New
Hedge Fund
$994K· 43.5% of total· 0.0% port· 79K sh· — QoQ· Q1 2026
New
Hedge Fund
$628K· 27.5% of total· 0.0% port· 50K sh· — QoQ· Q1 2026
New
Hedge Fund
$298K· 13.0% of total· 0.0% port· 24K sh· — QoQ· Q1 2026
New
Hedge Fund
$208K· 9.1% of total· 0.0% port· 17K sh· — QoQ· Q1 2026
New
Hedge Fund
$157K· 6.9% of total· 0.0% port· 13K sh· — QoQ· Q1 2026